Neurological outcome in patients with inborn errors of metabolism submitted to hematopoietic stem cell transplantation. What should we expect?

Marcos C. Lange

doi:10.1590/0004-282X20160165

Arquivos de Neuro-Psiquiatria, Table of Contents

CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2016; 74(12): 949-950
DOI: 10.1590/0004-282X20160165

EDITORIAL

Neurological outcome in patients with inborn errors of metabolism submitted to hematopoietic stem cell transplantation. What should we expect?

Desfecho neurológico em pacientes com erros inatos do metabolismo submetidos a transplante de células tronco hematopoiéticas. O que devemos esperar?

Marcos C. Lange

¹Universidade Federal do Paraná, Hospital de Clínicas, Serviço de Neurologia, Curitiba PR, Brasil.

› Author Affiliations

Abstract

Full Text

References

References
1 Mazzucato M, Visonà Dalla Pozza L, Manea S, Minichiello C, Facchin P. A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region’s rare diseases registry. Orphanet J Rare Dis. 2014;9:37. doi:10.1186/1750-1172-9-37
2 Valayannopoulos V. Enzyme replacement therapy and substrate reduction therapy in lysosomal storage disorders with neurological expression. Handb Clin Neurol. 2013;113:1851-7. doi:10.1016/B978-0-444-59565-2.00055-1
3 Saute JAM, Souza CFM, Poswar FO, Donis KC, Campos LG, Deyl AVS et al. Neurological outcomes after hematopoietic stem cell transplantation for cerebral X-linked adrenoleukodystrophy, late onset metachromatic leukodystrophy and Hurler syndrome. Arq Neuropsiquiatr. 2016;74(12):953-63. doi:10.1590/0004-282X20160155
4 Solders M, Martin DA, Andersson C, Remberger M, Andersson T, Ringdén O et al. Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy. Bone Marrow Transplant. 2014;49(8):1046-51. doi:10.1038/bmt.2014.93
5 Boucher AA, Miller W, Shanley R, Ziegler R, Lundt T, Raymond G et al. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report. Orphanet J Rare Dis. 2015;10:94. doi:10.1186/s13023-015-0313-y
6 Aldenhoven M, Wynn RF, Orchard PJ et al. Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood. 2015;125(13):2164-72. doi:10.1182/blood-2014-11-608075
7 Chiesa R, Wynn RF, Veys P. Haematopoietic stem cell transplantation in inborn errors of metabolism. Curr Opin Hematol. 2016;23(6):530-5. doi:10.1097/MOH.20160165201601650289
8 Eapen M, Ahn KW, Orchard PJ, Cowan MJ, Davies SM, Fash A et al. Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism. Biol Blood Marrow Transplant. 2012;18(9):1438-45. doi:10.1016/j.bbmt.2012.03.003